| regulation of angiotensin levels in blood | GO:0002002 | 4 | 0.843 | |
| renin angiotensin regulation of aldosterone production | GO:0002018 | 3 | 0.740 | |
| natural killer cell degranulation | GO:0043320 | 3 | 0.712 | |
| natural killer cell activation involved in immune response | GO:0002323 | 10 | 0.698 | |
| ceramide metabolic process | GO:0006672 | 31 | 0.693 | |
| regulation of angiotensin metabolic process | GO:0060177 | 4 | 0.638 | |
| peptide metabolic process | GO:0006518 | 46 | 0.636 | |
| vacuole organization | GO:0007033 | 38 | 0.606 | |
| immune effector process | GO:0002252 | 321 | 0.558 | |
| cell killing | GO:0001906 | 67 | 0.447 | |
| male sex differentiation | GO:0046661 | 109 | 0.441 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.431 | |
| membrane protein proteolysis | GO:0033619 | 10 | 0.428 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.379 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.364 | |
| granzyme mediated apoptotic signaling pathway | GO:0008626 | 1 | 0.359 | |
| renal system process | GO:0003014 | 48 | 0.350 | |
| organelle assembly | GO:0070925 | 177 | 0.333 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.333 | |
| positive regulation of leukocyte mediated cytotoxicity | GO:0001912 | 31 | 0.321 | |
| necrotic cell death | GO:0070265 | 30 | 0.295 | |
| antigen processing and presentation | GO:0019882 | 47 | 0.282 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.266 | |
| male gonad development | GO:0008584 | 88 | 0.266 | |
| kidney development | GO:0001822 | 213 | 0.256 | |
| antigen processing and presentation of peptide antigen | GO:0048002 | 29 | 0.250 | |
| developmental maturation | GO:0021700 | 193 | 0.234 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.212 | Human |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.204 | |
| protein processing | GO:0016485 | 163 | 0.202 | |
| regulation of cell killing | GO:0031341 | 40 | 0.198 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.194 | |
| renal system development | GO:0072001 | 225 | 0.182 | |
| antigen processing and presentation of exogenous peptide antigen | GO:0002478 | 21 | 0.177 | |
| gonad development | GO:0008406 | 141 | 0.171 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.166 | |
| hormone metabolic process | GO:0042445 | 86 | 0.165 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.163 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.163 | |
| antigen processing and presentation of exogenous antigen | GO:0019884 | 26 | 0.159 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.152 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.148 | |
| glycosphingolipid catabolic process | GO:0046479 | 5 | 0.137 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.134 | |
| protein autoprocessing | GO:0016540 | 2 | 0.132 | |
| epidermis development | GO:0008544 | 187 | 0.131 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.131 | |
| microtubule based transport | GO:0010970 | 50 | 0.130 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.130 | |
| regulation of systemic arterial blood pressure by circulatory renin angiotensin | GO:0001991 | 13 | 0.130 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.125 | |
| peptide hormone processing | GO:0016486 | 9 | 0.122 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.121 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.121 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.108 | |
| positive regulation of exocytosis | GO:0045921 | 20 | 0.108 | |
| oligosaccharide catabolic process | GO:0009313 | 2 | 0.107 | |
| glycolipid metabolic process | GO:0006664 | 25 | 0.107 | |
| regulation of protein stability | GO:0031647 | 52 | 0.105 | |
| hormone mediated signaling pathway | GO:0009755 | 23 | 0.102 | |
| cytoskeleton dependent intracellular transport | GO:0030705 | 50 | 0.101 | |
| positive regulation of natural killer cell mediated immunity | GO:0002717 | 16 | 0.101 | |
| autophagic vacuole assembly | GO:0000045 | 13 | 0.099 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.097 | |
| adaptive immune response | GO:0002250 | 155 | 0.097 | |
| angiogenesis | GO:0001525 | 201 | 0.095 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.093 | |
| maintenance of location | GO:0051235 | 89 | 0.090 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.090 | Rat |
| response to extracellular stimulus | GO:0009991 | 127 | 0.088 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.082 | |
| mesonephros development | GO:0001823 | 97 | 0.078 | |
| negative regulation of response to oxidative stress | GO:1902883 | 10 | 0.078 | |
| cation homeostasis | GO:0055080 | 212 | 0.076 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.074 | |
| protein maturation | GO:0051604 | 176 | 0.072 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.072 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.071 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.070 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.068 | |
| sphingolipid catabolic process | GO:0030149 | 7 | 0.068 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.068 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.068 | |
| regulation of systemic arterial blood pressure by renin angiotensin | GO:0003081 | 20 | 0.067 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.066 | |
| cellular homeostasis | GO:0019725 | 240 | 0.065 | |
| ceramide catabolic process | GO:0046514 | 7 | 0.064 | |
| natural killer cell mediated immunity | GO:0002228 | 29 | 0.063 | |
| positive regulation of necrotic cell death | GO:0010940 | 1 | 0.062 | |
| inflammatory response | GO:0006954 | 244 | 0.062 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.062 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.062 | |
| antigen processing and presentation of peptide or polysaccharide antigen via mhc class ii | GO:0002504 | 17 | 0.061 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.061 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.060 | |
| endocrine process | GO:0050886 | 39 | 0.058 | |
| microtubule based process | GO:0007017 | 236 | 0.058 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.057 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.057 | |
| glycolipid catabolic process | GO:0019377 | 5 | 0.057 | |
| cell recognition | GO:0008037 | 83 | 0.057 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.056 | |
| regulation of defense response | GO:0031347 | 233 | 0.056 | |
| calcium ion transport | GO:0006816 | 159 | 0.055 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.055 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.054 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.054 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.054 | |
| circulatory system process | GO:0003013 | 197 | 0.053 | |
| response to nutrient levels | GO:0031667 | 109 | 0.052 | |
| antigen processing and presentation of exogenous peptide antigen via mhc class ii | GO:0019886 | 14 | 0.052 | |
| feeding behavior | GO:0007631 | 62 | 0.051 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.050 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.050 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.050 | |
| macroautophagy | GO:0016236 | 21 | 0.050 | |
| leukocyte degranulation | GO:0043299 | 27 | 0.050 | |
| response to oxidative stress | GO:0006979 | 123 | 0.049 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.049 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.049 | |
| molting cycle | GO:0042303 | 90 | 0.047 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.046 | Human |
| extracellular structure organization | GO:0043062 | 148 | 0.046 | |
| multicellular organismal aging | GO:0010259 | 24 | 0.046 | Worm |
| male gamete generation | GO:0048232 | 285 | 0.045 | Rat |
| regulation of blood volume by renin angiotensin | GO:0002016 | 7 | 0.045 | |
| germ cell development | GO:0007281 | 185 | 0.045 | |
| membrane lipid catabolic process | GO:0046466 | 8 | 0.045 | |
| lipid catabolic process | GO:0016042 | 69 | 0.045 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.044 | |
| natural killer cell mediated cytotoxicity | GO:0042267 | 29 | 0.044 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.043 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.042 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.041 | |
| decidualization | GO:0046697 | 10 | 0.041 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.041 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.041 | |
| regulation of secretion | GO:0051046 | 274 | 0.041 | |
| skeletal system development | GO:0001501 | 356 | 0.040 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.040 | |
| lipid storage | GO:0019915 | 36 | 0.039 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.039 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.039 | |
| regulation of natural killer cell activation | GO:0032814 | 22 | 0.039 | |
| positive regulation of natural killer cell mediated cytotoxicity | GO:0045954 | 16 | 0.038 | |
| keratinocyte proliferation | GO:0043616 | 21 | 0.037 | |
| regulation of phosphatidylcholine catabolic process | GO:0010899 | 2 | 0.036 | |
| cation transport | GO:0006812 | 399 | 0.036 | |
| autophagy | GO:0006914 | 45 | 0.035 | Rat |
| neuron apoptotic process | GO:0051402 | 142 | 0.035 | |
| sphingosine metabolic process | GO:0006670 | 4 | 0.035 | |
| regulation of natural killer cell mediated immunity | GO:0002715 | 19 | 0.035 | |
| respiratory tube development | GO:0030323 | 167 | 0.035 | |
| sterol metabolic process | GO:0016125 | 58 | 0.034 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.033 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.032 | |
| antigen processing and presentation of peptide antigen via mhc class ii | GO:0002495 | 17 | 0.032 | |
| regulation of syncytium formation by plasma membrane fusion | GO:0060142 | 23 | 0.032 | |
| glycosylceramide metabolic process | GO:0006677 | 4 | 0.031 | |
| lung morphogenesis | GO:0060425 | 50 | 0.031 | |
| t cell mediated cytotoxicity | GO:0001913 | 26 | 0.030 | |
| regulated secretory pathway | GO:0045055 | 32 | 0.030 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.030 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.029 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.029 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.029 | |
| response to starvation | GO:0042594 | 65 | 0.029 | |
| muscle contraction | GO:0006936 | 101 | 0.029 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.028 | |
| spermatogenesis | GO:0007283 | 284 | 0.028 | Rat |
| positive regulation of macroautophagy | GO:0016239 | 3 | 0.028 | |
| protein stabilization | GO:0050821 | 25 | 0.028 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.028 | |
| cytokine production | GO:0001816 | 319 | 0.028 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.028 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.027 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.027 | |
| t cell activation | GO:0042110 | 289 | 0.027 | |
| gland development | GO:0048732 | 330 | 0.027 | |
| protein catabolic process | GO:0030163 | 221 | 0.027 | Human |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.026 | |
| neuronal action potential | GO:0019228 | 54 | 0.026 | |
| blood circulation | GO:0008015 | 195 | 0.026 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.026 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.025 | Human |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.025 | |
| positive regulation of cell killing | GO:0031343 | 33 | 0.025 | |
| endocytosis | GO:0006897 | 168 | 0.025 | Worm |
| regulation of cytokine production | GO:0001817 | 266 | 0.025 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.025 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.025 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.025 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.024 | |
| regulation of microtubule based process | GO:0032886 | 52 | 0.024 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.024 | |
| epithelial tube branching involved in lung morphogenesis | GO:0060441 | 28 | 0.024 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.024 | |
| regulation of system process | GO:0044057 | 200 | 0.024 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.024 | |
| l ascorbic acid metabolic process | GO:0019852 | 4 | 0.024 | |
| lipid localization | GO:0010876 | 126 | 0.024 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.023 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.023 | |
| cell maturation | GO:0048469 | 127 | 0.023 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.023 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.023 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.023 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.023 | |
| iron ion homeostasis | GO:0055072 | 36 | 0.023 | |
| regulation of cell activation | GO:0050865 | 289 | 0.022 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.022 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.022 | |
| cell adhesion | GO:0007155 | 329 | 0.022 | |
| negative regulation of keratinocyte proliferation | GO:0010839 | 7 | 0.022 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.022 | |
| organic acid transport | GO:0015849 | 101 | 0.022 | |
| protein lipid complex subunit organization | GO:0071825 | 12 | 0.022 | |
| regulation of neuron death | GO:1901214 | 134 | 0.022 | |
| cellular response to starvation | GO:0009267 | 57 | 0.022 | |
| t cell mediated immunity | GO:0002456 | 50 | 0.021 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.021 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.021 | |
| regulation of binding | GO:0051098 | 111 | 0.021 | |
| multicellular organismal catabolic process | GO:0044243 | 7 | 0.021 | Human |
| vacuolar transport | GO:0007034 | 11 | 0.021 | |
| regulation of hemostasis | GO:1900046 | 28 | 0.021 | |
| respiratory system development | GO:0060541 | 190 | 0.021 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.020 | |
| regulation of cell motility | GO:2000145 | 236 | 0.020 | |
| oxidation reduction process | GO:0055114 | 342 | 0.020 | |
| transmembrane transport | GO:0055085 | 412 | 0.020 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.020 | |
| hair cycle | GO:0042633 | 90 | 0.020 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.020 | |
| lysosomal transport | GO:0007041 | 10 | 0.020 | |
| regulation of erbb signaling pathway | GO:1901184 | 16 | 0.019 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.019 | |
| acetylcholine transport | GO:0015870 | 2 | 0.019 | |
| response to monosaccharide | GO:0034284 | 67 | 0.019 | Rat |
| nerve development | GO:0021675 | 67 | 0.019 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.019 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.019 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.019 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.019 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.019 | |
| circadian sleep wake cycle rem sleep | GO:0042747 | 1 | 0.019 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.019 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.018 | |
| negative regulation of erbb signaling pathway | GO:1901185 | 7 | 0.018 | |
| response to steroid hormone | GO:0048545 | 56 | 0.018 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.018 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.018 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.018 | |
| lipid modification | GO:0030258 | 65 | 0.018 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.018 | |
| regulation of regulated secretory pathway | GO:1903305 | 20 | 0.018 | |
| prostate gland development | GO:0030850 | 48 | 0.018 | |
| regulation of immunological synapse formation | GO:2000520 | 2 | 0.017 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.017 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.017 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.017 | |
| wound healing | GO:0042060 | 157 | 0.017 | Zebrafish |
| liposaccharide metabolic process | GO:1903509 | 27 | 0.017 | |
| sterol transport | GO:0015918 | 38 | 0.017 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.017 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.017 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.017 | |
| organic anion transport | GO:0015711 | 137 | 0.016 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.016 | |
| fibrinolysis | GO:0042730 | 3 | 0.016 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.016 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.016 | |
| regulation of myeloid cell apoptotic process | GO:0033032 | 19 | 0.016 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.016 | |
| negative regulation of cellular response to oxidative stress | GO:1900408 | 10 | 0.016 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.016 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.016 | |
| lysosome organization | GO:0007040 | 21 | 0.015 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.015 | |
| cell cell recognition | GO:0009988 | 44 | 0.015 | |
| amyloid precursor protein biosynthetic process | GO:0042983 | 3 | 0.015 | |
| positive regulation of neutrophil apoptotic process | GO:0033031 | 1 | 0.015 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.015 | Human |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.015 | |
| protein localization to vacuole | GO:0072665 | 4 | 0.015 | |
| lung development | GO:0030324 | 164 | 0.015 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.015 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.015 | |
| muscle system process | GO:0003012 | 141 | 0.015 | |
| phospholipid transfer to membrane | GO:0006649 | 2 | 0.015 | |
| water soluble vitamin biosynthetic process | GO:0042364 | 3 | 0.015 | |
| camera type eye development | GO:0043010 | 266 | 0.015 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.015 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.014 | |
| female gamete generation | GO:0007292 | 74 | 0.014 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.014 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.014 | |
| muscle cell development | GO:0055001 | 133 | 0.014 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.014 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.014 | |
| microtubule based movement | GO:0007018 | 84 | 0.014 | |
| cell chemotaxis | GO:0060326 | 81 | 0.014 | |
| regulation of keratinocyte proliferation | GO:0010837 | 15 | 0.014 | |
| positive regulation of membrane protein ectodomain proteolysis | GO:0051044 | 3 | 0.014 | |
| catagen | GO:0042637 | 5 | 0.014 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.014 | |
| negative regulation of platelet derived growth factor receptor alpha signaling pathway | GO:2000584 | 2 | 0.014 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.014 | |
| striated muscle cell development | GO:0055002 | 125 | 0.014 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.013 | |
| eosinophil migration | GO:0072677 | 3 | 0.013 | |
| forebrain radial glial cell differentiation | GO:0021861 | 4 | 0.013 | |
| sertoli cell differentiation | GO:0060008 | 18 | 0.013 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.013 | |
| sensory system development | GO:0048880 | 3 | 0.013 | |
| regulation of natural killer cell mediated cytotoxicity | GO:0042269 | 19 | 0.013 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.013 | |
| defense response to bacterium | GO:0042742 | 119 | 0.013 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.013 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.013 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.013 | |
| hair cycle phase | GO:0044851 | 16 | 0.013 | |
| ceramide biosynthetic process | GO:0046513 | 20 | 0.013 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.013 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.013 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.013 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.013 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.013 | |
| lipid transport | GO:0006869 | 98 | 0.013 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.013 | |
| organ growth | GO:0035265 | 117 | 0.013 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.013 | |
| myelination | GO:0042552 | 74 | 0.013 | |
| lateral line system development | GO:0048925 | 1 | 0.013 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.013 | |
| notochord cell differentiation | GO:0060034 | 1 | 0.012 | |
| intracellular sterol transport | GO:0032366 | 3 | 0.012 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.012 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.012 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.012 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.012 | |
| regulation of protein transport | GO:0051223 | 163 | 0.012 | |
| response to acid chemical | GO:0001101 | 111 | 0.012 | |
| regulation of leukocyte degranulation | GO:0043300 | 20 | 0.012 | |
| lymphocyte costimulation | GO:0031294 | 15 | 0.012 | |
| single fertilization | GO:0007338 | 82 | 0.012 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.012 | |
| skin development | GO:0043588 | 220 | 0.012 | |
| blood coagulation | GO:0007596 | 76 | 0.012 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.012 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.012 | |
| fertilization | GO:0009566 | 127 | 0.012 | |
| action potential | GO:0001508 | 78 | 0.012 | |
| natural killer cell activation | GO:0030101 | 44 | 0.012 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.011 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.011 | |
| defense response to other organism | GO:0098542 | 197 | 0.011 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.011 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.011 | |
| protein oligomerization | GO:0051259 | 67 | 0.011 | |
| neuron projection regeneration | GO:0031102 | 14 | 0.011 | |
| cellular response to hydroperoxide | GO:0071447 | 4 | 0.011 | |
| glycosaminoglycan metabolic process | GO:0030203 | 34 | 0.011 | |
| tissue homeostasis | GO:0001894 | 115 | 0.011 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.011 | |
| urogenital system development | GO:0001655 | 261 | 0.011 | |
| myosin filament organization | GO:0031033 | 3 | 0.011 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.011 | |
| positive regulation of regulated secretory pathway | GO:1903307 | 10 | 0.011 | |
| skin morphogenesis | GO:0043589 | 38 | 0.011 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.011 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.011 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.011 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.011 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.011 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.010 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.010 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.010 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.010 | |
| myosin filament assembly | GO:0031034 | 2 | 0.010 | |
| learning or memory | GO:0007611 | 148 | 0.010 | |
| thymocyte migration | GO:0072679 | 2 | 0.010 | |
| lateral inhibition | GO:0046331 | 1 | 0.010 | |
| positive regulation of leukocyte degranulation | GO:0043302 | 10 | 0.010 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.010 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.010 | |
| bone development | GO:0060348 | 120 | 0.010 | |
| negative regulation of vesicle fusion | GO:0031339 | 1 | 0.010 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.010 | |
| blastocyst development | GO:0001824 | 80 | 0.010 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.010 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.010 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.010 | Rat |
| plasma cell differentiation | GO:0002317 | 3 | 0.010 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.010 | |
| regulation of exocytosis | GO:0017157 | 61 | 0.010 | |
